Rajdeep Kakar
Sleep Medicine · Plano, TXNPI 1073530986
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,077 of the $1,238 with a category attached, or 87.0%. 12 manufacturers reported payments, led by Harmony Biosciences LLC at 48.9% of the total. Reporting peaked in 2023 at $310 and has fallen 57.5% since, to $132 in 2025. That places this record below the midpoint for sleep medicine clinicians in TX, where the typical reported total is $1,720.
Across 63 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$605
- Jazz Pharmaceuticals Inc.$228
- Inspire Medical Systems, Inc.$184
- Idorsia Pharmaceuticals US Inc$36
- Resmed Corp$36
- Philips North America LLC$31
- plus $117 from 6 others
What the payments were for
- Consulting fees$161%
- Food & beverage$1,07787%
- Education$14512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 34 | $605 |
| Jazz Pharmaceuticals Inc. | 11 | $228 |
| Inspire Medical Systems, Inc. | 6 | $184 |
| Idorsia Pharmaceuticals US Inc | 2 | $36 |
| Resmed Corp | 2 | $36 |
| Philips North America LLC | 2 | $31 |
| Ensodata, Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $19 |
| ZOLL Respicardia, Inc. | 1 | $18 |
| Itamar Medical Inc | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
How this compares
$1,238 in reported general payments places this provider in the 40th percentile of 112 sleep medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $235 |
| Zolpidem Tartrate | 18 | $115 |
| Trazodone Hcl | 15 | $37 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Plano
- Khanh TruongPlano$10K
- Michael KellamPlano$10K
- Gerard MeskillSugar Land$1M
- Vikas JainFrisco$673K
- Amit VermaHouston$493K
- Jerald SimmonsHouston$165K
- James AndrySan Antonio$100K
- William BurkesBeaumont$99K
- Ashwin GowdaAustin$71K
- John DebusDallas$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.